Emergent BioSolutions discarded ingredients for 400 million COVID-19 vaccines, Congressional probe finds

Emergent BioSolutions discarded ingredients for 400 million COVID-19 vaccines, probe finds Between March 2020 and February 2022, vaccine-maker Emergent BioSolutions was forced to discard or destroy up to 400 million coronavirus vaccine doses due to the contamination of ingredients, according to a congressional report published Tuesday -- a figure that reflects more than five times what was previously disclosed by the beleaguered firm. Congressional investigators probing the Maryland-based biotech company found that Emergent executives had privately raised urgent quality-control concerns even before the company began manufacturing the vaccines' key ingredient -- despite publicly expressing confidence in their ability to deliver on their multimillion-dollar government contract. Meanwhile, according to the report, Emergent lab workers intentionally sought to mislead government inspectors about issues at its Bayview, Maryland, plant, and repeatedly "rebuffed" efforts by AstraZeneca and Johnson & Johnson to inspect their facilities. YahooNews

...

None of the compromised batches of the ingredient in question made it into finished vaccine doses released from Emergent's plant, the committees said.

...